Lv34
270 积分 2023-06-12 加入
Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
6小时前
已完结
Overtreatment of multiple myeloma and its precursor states: de-escalation is an urgent need in clinical practice and trials
1天前
已完结
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma
1天前
已完结
Response-Adapted Therapy for Newly Diagnosed Multiple Myeloma
2天前
已完结
Treatment of Newly Diagnosed Multiple Myeloma: A Real-world Study in A Western Single Center of China
2天前
求助中
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
7天前
已完结
OPTN/SRTR 2023 Annual Data Report: Kidney
8天前
已完结
Lower tacrolimus time in therapeutic range is associated with inferior outcomes in adult liver transplant recipients
13天前
已完结
Optimising salvage therapy for Hodgkin lymphoma: progress and future challenges
14天前
已完结
Optimizing Second-Line Therapy for Hodgkin Lymphoma: A Work in Progress
14天前
已完结
皖公网安备34019202002308
